Squarepoint’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Squarepoint’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-24,773	Closed	-$445K	–	2460
2017 Q4	$445K	Buy	+24,773	New	+$305K	0.01%	1279
2017 Q3	–	Sell	-24,808	Closed	-$260K	–	2034
2017 Q2	$260K	Sell	24,808 -6,360	-20%	-$64.8K	0.01%	1201
2017 Q1	$343K	Buy	31,168 +8,831	+40%	+$102K	0.01%	1028
2016 Q4	$303K	Buy	+22,337	New	+$312K	0.01%	1147
2016 Q3	–	Sell	-11,600	Closed	-$127K	–	1418
2016 Q2	$127K	Buy	+11,600	New	+$130K	0.01%	961
2016 Q1	–	Sell	-18,600	Closed	-$322K	–	1614
2015 Q4	$322K	Buy	+18,600	New	+$333K	0.04%	770

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Squarepoint's SCMP Position: Q1 2018 in Review

Squarepoint sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 24,773 shares — an estimated $445K sold.

Squarepoint first reported a position in SCMP in Q4 2015 and held it in 6 quarters. The position peaked at $445K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Squarepoint reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Squarepoint sold 24,773 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $445K.
Squarepoint first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2015 and held it in 6 quarters.
Squarepoint's Sucampo Pharmaceuticals, Inc. position peaked at $445K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Squarepoint's 13F filing for Q1 2018, filed 15 May 2018.